Delivery Order SPE2DB22D3011-SPE2DB24FP7LU
- Not listed
- This federal contract award, valued at $58,061.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award, valued at $22,530.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $91,048.75, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The contract has a firm fixed price pricing type and a period of performance ending on November 21, 2022. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, with a ceiling value of $127,579.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,246,607 MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2025. It is not designated as a set-aside contract, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,903.12 with a firm fixed price. The contract covers the supply of "MENQUADFI VIAL 0.5ML" medical products to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,911.68 firm fixed-price delivery order covers the supply of 4567773275 MENQUADFI VIAL 0.5ML, a medical product, with a period of performance through April 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This contract award, valued at $14,515.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award is a Delivery Order with a Firm Fixed Price contract type valued at $85,619.69, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of MENQUADFI VIAL 0.5ML, a medical product, with a performance period ending on June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $7,419.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award is a delivery order valued at $1,452.88 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENQUADFI VIAL 0.5ML, with a completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP7LUDelivery Order
This federal contract award, valued at $73,401.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of MENQUADFI VIAL 0.5ML, a medical product, with an ultimate completion date of November 3, 2023. This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for supplying these medical products to support military healthcare programs and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $73.4k | 11/2/23 |